Blackwell Kimberly
CIK 0001816465
President & CEODirector
Filings
13
Latest Jun 16, 2025
Issuers covered
3
Showing
13 of 13
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +38.1% | +38.1% | +47.9% | +28.4% |
| 90 days | 2 | 100% | +23.7% | +23.7% | +35.4% | +12.1% |
| 180 days | 2 | 100% | +38.3% | +38.3% | +62.1% | +14.5% |
| 365 days | 2 | 50% | +5.3% | +5.3% | +74.5% | -63.8% |
Issuers
Companies where Blackwell Kimberly has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | 5 | Feb 5, 2024 |
| IPSC | Century Therapeutics, Inc. | 4 | Jun 16, 2025 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4 | Jun 16, 2025 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|